3SOF

Hi

Stockguru.com: Price and Volume Alerts for Thursday August 10, 2006 - One Company Announces 2006 Second Quarter Results Another Launches My Tel Co, Inc.

Addison-Davis Diagnostics, Inc. (ADSD) - Wednesday's shares closed down at -13.04% with a price of $0.0200. The volume was at 354,500. Addison-Davis Diagnostics, Inc. is pleased to announce the signing of a distribution agreement with PharTech Solutions, Inc. ("PharTech") to make its DrugStop product available through PharTech's telecommunications networks to medical offices and small to medium sized businesses nationwide. Addison-Davis CEO Charles Miseroy says, "I believe that this association, introducing a direct-market medium, should further expand the sources to which Drug Stop may be sold." PharTech provides already-established relationships with business and institutional accounts.
Food and Drug Administration ("FDA") 510(k) cleared, DrugStop is a completely self-contained and self-regulating, on-site drug testing product that uses a rapid immunoassay for the qualitative detection of drug metabolites in urine. Drugstop eliminates specimen exposure, reduces the chances of complications in handling, and is the only test available that does not require processing once the sample is collected. Drugstop is designed for human resource professionals for testing a number of different types of drugs including amphetamines, cocaine, opiates, phencyclidine, and cannabinoids.
For a quote and the latest news on this company, please visit: http://www.stockguru.com/profiles/ADSD.php .


HEADLINERS ENTMT GROUP INC | HLEG
Aug. 9, 2006 Market Closed   Common Stock Market : OTCBB   

Last Sale: $ 0.0074                           Net Change: 0.0003  4.23%
Share Volume: 788,900                     Previous Close: $ 0.0071
Today's High: $ 0.0077                     Today's Low: $ 0.0071
Best Bid: N/A                                   Best Ask: N/A
52 Week High: $ 0.28                       52 Week Low: $ 0.005
P/E Ratio: 0                                     Shares Outstanding: 35,000,000
Earnings Per Share (EPS): $ 21.75      Market Value: $ 259,000

Hi

BUYINS.NET: UQM, ADSD, SOIGF Have Also Been Removed From Naked Short List Today
Friday , August 11, 2006 09:18 ET
Addison-Davis Diagnostics, Inc. (OTCBB: ADSD) primarily offers diagnostic products. Its diagnostic platform is designed for point-of-care and ambulatory use, and incorporates a single-use disposable specimen collection device. The company's desktop analyzer is capable of detecting data for Myoglobin, CK-MB, Cardiac Troponin-1, and GP-BB, as well as the presence and volume of cocaine. The analyzer can be used in clinics and doctor's offices, as well as in emergency rooms. Addison-Davis is also developing a hand-held mobile multiple assay analyzer that would incorporate the patented technology for specimen collection and provide results for various cardiac and blood-born metrics. In addition, the company engages in the development and commercialization of Drug Stop, a FDA cleared rapid urinalysis test for drugs of abuse, for professional and over-the-counter use. The company was formerly known as QT 5, Inc. and changed its name to Addison-Davis Diagnostics, Inc. in November 2004. Addison-Davis is based in Westlake Village, California. With 1.23 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of ADSD.

Hi
ADSD Removed From Naked Short List 08/11/2006 it will be possible within the next few days good speculative game. (only my opinion)   

Hi


Stockguru.com: Morning Updates for Tuesday, August 15,2006 - While One Company Announces New Distrubution Agreement Another Company Announces New Product Received EPA Registration

Tuesday , August 15, 2006 07:11 ET

Addison-Davis Diagnostics, Inc. (OTCBB: ADSD) - Monday's shares went up 11.11% to $0.025 with a total of 185,286 shares traded. On Jun 12, 2006, Addison-Davis Diagnostics, Inc. announces the signing of a distribution agreement with PharTech Solutions, Inc. ("PharTech") to make its DrugStop product available through PharTech's telecommunications networks to medical offices and small to medium sized businesses nationwide. Addison-Davis CEO Charles Miseroy says, "I believe that this association, introducing a direct-market medium, should further expand the sources to which Drug Stop may be sold." PharTech provides already-established relationships with business and institutional accounts.
Addison-Davis Diagnostics, Inc. is responding to industry demands by supplying quick response diagnostic tests that are user friendly, produce fast simple results and are less costly, less problematic and less time consuming. Addison-Davis is currently focused on bringing fast and reliable Point-of-care" Diagnostic Testing through the use of its patented technology to Healthcare Professionals, Hospitals, certain branches of the Government and the Workplace environment for drugs-of-abuse and medical conditions and diseases. For more information, please visit the website at www.addisondavis.com or contact Matt Maguire at 1-866-THE APPL(E).
For a quote and the latest news on this company, please visit: http://www.stockguru.com/profiles/ADSD.php

Hi
ADSD +20% 

Hi

Hi

Hi

Hi
Look ADSD +25%

Hi

Hi
I love speculative game 

Hi
ADSD: Short Interest UP 112688.9% to 10.2K in Aug 2006

Friday , August 25, 2006 06:00 ET

According to new short interest data from OTCBB.com, short interest for Addison-Davis Diagnostics, Inc. (OTCBB: ADSD) INCREASED 112688.9% to 10,151 shares for the month ended mid-August, 2006.

SYMBOL              JULY          AUGUST          CHANGE       %CHANGE  DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
ADSD                   9          10,151         +10,142   +112688.89%           1

Based on ADSD's 20-day average daily share volume of 236,019, it would require approximately 1 day(s) of buying to cover this short interest.



Open Gaps
Direction Date range
up Aug-24-2006 0.025 to 0.027
up Apr-18-2006 to 0.15
down Aug-23-2006 0.028 to 0.025
down Jul-17-2006 0.039 to 0.038
http://www.stockta.com/cgi-bin/analysis.pl?symb=adsd&num1=2&cobrand=TV

Hi

BUYINS.NET: CBAK, ADSD, ARGA, ASIQ, EGIL, FORD Have Been Removed From Naked Short List Today

Monday , August 28, 2006 09:42 ET

Addison-Davis Diagnostics, Inc. (OTCBB: ADSD) primarily offers diagnostic products. Its diagnostic platform is designed for point-of-care and ambulatory use, and incorporates a single-use disposable specimen collection device. The company's desktop analyzer is capable of detecting data for Myoglobin, CK-MB, Cardiac Troponin-1, and GP-BB, as well as the presence and volume of cocaine. The analyzer can be used in clinics and doctor's offices, as well as in emergency rooms. Addison-Davis is also developing a hand-held mobile multiple assay analyzer that would incorporate the patented technology for specimen collection and provide results for various cardiac and blood-born metrics. In addition, the company engages in the development and commercialization of Drug Stop, a FDA cleared rapid urinalysis test for drugs of abuse, for professional and over-the-counter use. The company was formerly known as QT 5, Inc. and changed its name to Addison-Davis Diagnostics, Inc. in November 2004. Addison-Davis is based in Westlake Village, California. With 1.23 million shares outstanding and 10,151 shares declared short as of August 2006, there is no longer a failure to deliver in shares of ADSD.

Hi
Recent CandleStick Analysis
Very Bullish
Date Candle
Aug-28-2006 Bullish Engulfing 

Hi